$REPX Balance Sheet | Understand Stock

$REPX

$52.41 -$0.41 (0.78%) Close

$REPX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current Assets:
Cash and cash equivalents
Cash
Accounts receivable, net
Accounts receivable - related parties
Prepaid expenses and other current assets
Receivables from oil, natural gas and NGL sales
Prepaid expenses
Inventory
Current derivative assets
Total Current Assets

Oil and natural gas properties, net (successful efforts)
Other property and equipment, net
Non-current derivative assets
Equity method investment
Funds held in escrow
Other non-current assets, net
Total Assets
Liabilities and Shareholders' Equity
Current Liabilities:
Accounts payable
Nonrelated Party
Total accounts payable
Accounts payable - related parties
Accrued liabilities
Revenue payable
Income taxes payable
Advances from joint interest owners
Current derivative liabilities
Current portion of long-term debt
Other current liabilities
Total Current Liabilities

Non-current derivative liabilities
Asset retirement obligations
Long-term debt
Deferred tax liabilities
Other non-current liabilities
Total Liabilities
Series A Preferred Units
Members' Equity
Shareholders' Equity:
Preferred stock, $0.0001 par value, 25,000,000 shares authorized; 0 shares issued
Common stock, $0.001 par value, 240,000,000 shares authorized; 22,173,260 and 21,718,800 shares issued at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Retained earnings
Total Shareholders' Equity
Total Liabilities and Shareholders' Equity

Common stock outstanding post merger (in Shares)

Comments